Three triazatruxene-based donors Tr-Me, Tr-Ph, and Tr-Tol were intermixed with three acceptors 3P-T2T, 3P-T2P, and 3P-Pyr equipping with different heteroarene cores to generate an array of nine blends to probe the feasibility of exciplex formation.
In this study, a new triazatruxene-based donor Tr-iBu bearing branched alkyl groups is reported to suppress the aggregation found in a previously reported methyl-substituted counterpart Tr-Me. The effects of a steric factor on the propensity of exciplex formation were examined by respectively mixing these triazatruxene-based donors with PO-T2T and two new acceptors PO-T2P and PO-Pyr, all bearing phosphine oxide as the peripheral groups and N-heteroarene cores with different numbers of nitrogen. Based on the steric hindrance of side groups and their corresponding molecular orbitals alignments of donors and acceptors, the characteristics of exciplex-forming systems were analyzed. Among them, the exciplex-forming blends Tr-iBu:PO-T2P and Tr-iBu:PO-Pyr were selected to serve as the emitting layer (EML) to achieve OLED devices with a moderate maximum external quantum efficiency (EQE max ) of 8.27 and 7.54%, respectively. Adopting the Förster resonance energy transfer strategy, the exciplex cohost was doped with a fluorescence emitter, DPy2CN, to realize a deep-red OLED device with the emission peak centered at 674 nm while retaining EQE max of 6.28%. Our results highlight the importance of suppressing the donor aggregation, adequate donor: acceptor combination, and a suitable triplet state of composing the materials for giving efficient exciplex-based OLEDs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.